Measurement of Urinary Catabolites of PACs as Biomarkers of Consumption of Cranberry Extracts
Phase 1
Completed
- Conditions
- Urinary Tract Infections
- Interventions
- Dietary Supplement: Cranberry extract
- Registration Number
- NCT02087735
- Lead Sponsor
- Laval University
- Brief Summary
The purpose of this cross over pilot study is to investigate the urinary catabolites of Proanthocyanidines (PACs) as biomarkers of cranberry extracts in healthy young women.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 15
Inclusion Criteria
- Healthy women.
- 18 to 40 years.
Exclusion Criteria
- No internet access.
- No refrigerator access during the 9 hours of sample collection.
- Women who had or expect to take antibiotic.
- Women who had or expect to take cranberries, blueberries or bilberries in the form of berries, juice or extracts.
- Women who had or expect to take dark chocolate.
- Women who had personal history of acute or chronic renal failure.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description cranberry extract 3. Cranberry extract Two capsules with a proanthocyanidin standardized cranberry extract of 2 mg. cranberry extract 2. Cranberry extract Two capsules with a proanthocyanidin standardized cranberry extract of 36 mg. cranberry extract 1 Cranberry extract One capsule with a proanthocyanidin standardized cranberry extract of 36 mg and one capsule of placebo cranberry extract.
- Primary Outcome Measures
Name Time Method Urinary catabolites of PACs within 9 hours following the intake of cranberry extracts
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Laval University, Department of Medecine, Institut sur la nutrition et les aliments fonctionnels (INAF).
🇨🇦Québec, Quebec, Canada